The American regulator granted the status of accelerated consideration of the application for carbetocin – an analogue of oxytocin, for intranasal administration
Scientists from Imperial College London have managed to reduce the period of laboratory research on the development of COVID-19 vaccine up to two weeks.
American researchers have carried out a comparative analysis of two methods of delivering insulin to the human body to control glycemia. It turned out that a plaster to be as effective and safe as a syringe pen.
Scientists have started the first test of the new type of COVID-19 vaccine.
Danish scientists have found an interrelation between fish oil-based dietary supplements and increased male fertility in an observational study.
For the treatment of obsessive-compulsive disorder the new drug is fully developed by Exscientia Artificial Intelligence at Oxford. The drug is already preparing for testing in humans.
Scientists from the University of California have carried out the first clinical trial of a cure for stuttering. Only 9 patients took part in the test, however, almost all subjects had improved their speech.
The new scanner uses a 130 tons super magnet with the help of which doctors hope to get the opportunity for early diagnosis of many brain diseases.
A new clinical practice guideline by the International Society for Dietary Psychiatry Research recommends omega-3 polyunsaturated fatty acids as an adjunctive therapy for major depressive disorder.
Swiss scientists have determined that a period of 30 to 32 years is the perfect age for treating multiple sclerosis. If you delay the start of treatment for multiple sclerosis up to 40 years, then the risk of disability increases significantly.